Lab-on-a-chip technology may simplify cancer detection

Their method can analyse and identify multiple targets on a silicon-based molecular detection platform. Laboratory-on-a-chip describes the miniaturisation of laboratory functions such as blood testing on a chip.

Instead of transferring relatively large (micro- to millilitres) samples between test tubes or using bulky analytical equipment, samples and reagents are handled on chip-scale devices with fluidic microchannels.

This requires much smaller test volumes, and multiple functions can be integrated on a single device, improving speed, reliability and portability of these lab processes. “Our approach uses optofluidic chips where both fluid
processing and optical sensing are done on a chip, allowing for further miniaturisation and performance enhancements of the chip system,” said Holger Schmidt, professor at the University of California, Santa Cruz.

Read: First boron detection on Mars points to habitability

Each of the chips had to be developed and tested for multiple functions, from filtering of blood cells without clogging the filter to reliably analysing optical data to create the right excitation patterns on the silicon chip.

The next step to realising the potential of this research is to move towards real clinical samples and to detect individual DNA biomarkers. “We have shown single nucleic acid analysis in the context of on-chip Ebola detection and would like to transfer that to this application,” said Schmidt.

Other goals for the team include increasing the speed of the analysis process, and integrating more optical elements on the chip. They also want to expand their capabilities to analysing protein biomarkers in addition to nucleic acids and whole virus particles already demonstrated.

This research is expected to have a wide range of applications because the underlying principle of this kind of on-chip optical analysis and manipulation is very general. “In the near term, we hope to build new diagnostic instruments for molecular diagnostics with applications in oncology and infectious disease detection, both viruses and (drug-resistant) bacteria,” Schmidt said.